Dr Colby Lee Edwards, DO | |
4200 S Douglas Ave Ste 306, Ismc Emergency Medicine, Oklahoma City, OK 73109-3215 | |
(405) 636-7195 | |
Not Available |
Full Name | Dr Colby Lee Edwards |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 4200 S Douglas Ave Ste 306, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114093655 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 4400 (Oklahoma) | Primary |
Entity Name | Mercy Clinic Oklahoma Communities |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
The researchers at the U School of Medicine made the finding by tracing variations in the DNA of an extended Utah family that has a high occurrence of the disorder and whose members are descended from one couple.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
In a small, preliminary study that included 13 male children, those with autism had an average 67 percent more prefrontal brain neurons and larger than average brain weight, than children without autism, according to a study in the Nov. 9 issue of JAMA.
› Verified 2 days ago
Entity Name | Emergency Services Of Oklahoma Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215249891 PECOS PAC ID: 8123209012 Enrollment ID: O20110225000085 |
News Archive
The researchers at the U School of Medicine made the finding by tracing variations in the DNA of an extended Utah family that has a high occurrence of the disorder and whose members are descended from one couple.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
In a small, preliminary study that included 13 male children, those with autism had an average 67 percent more prefrontal brain neurons and larger than average brain weight, than children without autism, according to a study in the Nov. 9 issue of JAMA.
› Verified 2 days ago
Entity Name | Oklahoma Emergency Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114239795 PECOS PAC ID: 3678757010 Enrollment ID: O20110411000211 |
News Archive
The researchers at the U School of Medicine made the finding by tracing variations in the DNA of an extended Utah family that has a high occurrence of the disorder and whose members are descended from one couple.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
In a small, preliminary study that included 13 male children, those with autism had an average 67 percent more prefrontal brain neurons and larger than average brain weight, than children without autism, according to a study in the Nov. 9 issue of JAMA.
› Verified 2 days ago
Entity Name | Emergency Physicians Of Mid-america Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063825297 PECOS PAC ID: 2062638661 Enrollment ID: O20140716001692 |
News Archive
The researchers at the U School of Medicine made the finding by tracing variations in the DNA of an extended Utah family that has a high occurrence of the disorder and whose members are descended from one couple.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
In a small, preliminary study that included 13 male children, those with autism had an average 67 percent more prefrontal brain neurons and larger than average brain weight, than children without autism, according to a study in the Nov. 9 issue of JAMA.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Colby Lee Edwards, DO 1212 Mary Lee Ln, Edmond, OK 73034-5427 Ph: (405) 471-6112 | Dr Colby Lee Edwards, DO 4200 S Douglas Ave Ste 306, Ismc Emergency Medicine, Oklahoma City, OK 73109-3215 Ph: (405) 636-7195 |
News Archive
The researchers at the U School of Medicine made the finding by tracing variations in the DNA of an extended Utah family that has a high occurrence of the disorder and whose members are descended from one couple.
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has been issued U.S. Patent No. 7,883,872 entitled, Construction of Highly Efficient Cellulase Compositions for Enzymatic Hydrolysis of Cellulose, by the United States Patent and Trademark Office ("USPTO").
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
In a small, preliminary study that included 13 male children, those with autism had an average 67 percent more prefrontal brain neurons and larger than average brain weight, than children without autism, according to a study in the Nov. 9 issue of JAMA.
› Verified 2 days ago
Dr. Hunter Dale Cook, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7709 | |
Alejandro Anzaldua, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 900 Ne 10th St, Fmc 2102, Oklahoma City, OK 73104 Phone: 405-271-2230 | |
Dr. Diana Dee Mills-maloney, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10312 Creek Meadow Dr, Oklahoma City, OK 73151 Phone: 405-771-3577 | |
Dr. David Brennan, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7000 | |
Aaron Daniel Jones, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7000 | |
Dr. David M. Abercrombie, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1624 Grey Fox Run, Oklahoma City, OK 73131 Phone: 405-478-3969 Fax: 405-478-3815 | |
Dr. Amy L. Sparkman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 940 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-271-2429 |